TrinityPoint Wealth »

Coherus Biosciences shares owned by TrinityPoint Wealth

Quarter-by-quarter ownership of Coherus Biosciences (CHRS) shares owned by TrinityPoint Wealth from 13F filings

Historical chart of TrinityPoint Wealth investment in Coherus Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Coherus Biosciences held by TrinityPoint Wealth consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Coherus Biosciences by TrinityPoint Wealth

Quarter filed Position value Share count Share price at filing
2023-12-31 $40k 12k 3.33

More positions owned by TrinityPoint Wealth

Apple (AAPL)
Alphabet Cap Stk Cl C (GOOG)
Microsoft Corporation (MSFT)
Schwab Strategic Tr Us Dividend Eq (SCHD)
Amazon (AMZN)
Schwab Strategic Tr Us Brd Mkt Etf (SCHB)
Invesco Exchange Traded Fd T S&p 500 Garp Etf (SPGP)
Select Sector Spdr Tr Sbi Healthcare (XLV)
Abbvie (ABBV)
CVS Caremark Corporation (CVS)
Honeywell International (HON)
Alphabet Cap Stk Cl A (GOOGL)
Select Sector Spdr Tr Technology (XLK)
Merck & Co (MRK)
UnitedHealth (UNH)

View all positions for TrinityPoint Wealth

Top funds holding Coherus Biosciences

Vanguard Group
Barclays
Kohlberg Kravis Roberts & Co
Millennium Management
Citadel Advisors
Bank of America Corporation
CAM Group Holding A/S
Jacobs Levy Equity Management
Two Sigma Investments
Deutsche Bank Aktiengesellschaft
Peregrine Capital Management
AlphaCentric Advisors
Goldman Sachs Group
CM Management
Charles Schwab Investment Management

View all funds holding Coherus Biosciences